ID   PBIR1_RAT               Reviewed;         286 AA.
AC   Q6AYT4;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2004, sequence version 1.
DT   29-MAY-2024, entry version 105.
DE   RecName: Full=P2R1A-PPP2R2A-interacting phosphatase regulator 1 {ECO:0000250|UniProtKB:Q96E09};
DE   AltName: Full=PABIR family member 1 {ECO:0000250|UniProtKB:Q96E09};
GN   Name=Pabir1 {ECO:0000250|UniProtKB:Q96E09};
GN   Synonyms=Fam122a {ECO:0000312|RGD:1310316};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-61; SER-75; SER-142; SER-146;
RP   SER-188 AND SER-269, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Acts as an inhibitor of serine/threonine-protein phosphatase
CC       2A (PP2A) activity. Potentiates ubiquitin-mediated proteasomal
CC       degradation of serine/threonine-protein phosphatase 2A catalytic
CC       subunit alpha (PPP2CA) (By similarity). Inhibits PP2A-mediated
CC       dephosphorylation of WEE1, promoting ubiquitin-mediated proteolysis of
CC       WEE1, thereby releasing G2/M checkpoint (By similarity).
CC       {ECO:0000250|UniProtKB:Q96E09}.
CC   -!- SUBUNIT: Interacts with PPP2CA, PPP2R2A and PPP2R1A (By similarity).
CC       The CHEK1-mediated Ser-36 phosphorylated form interacts with 14-3-3
CC       proteins (By similarity). {ECO:0000250|UniProtKB:Q96E09}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q96E09}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q96E09}. Note=The CHEK1-mediated Ser-36
CC       phosphorylated form is sequestered by 14-3-3 proteins in the cytoplasm
CC       and fails to translocate to the nucleus, where it otherwise inhibits
CC       serine/threonine-protein phosphatase 2A.
CC       {ECO:0000250|UniProtKB:Q96E09}.
CC   -!- PTM: CHEK1-mediated phosphorylation at Ser-36 negatively regulates its
CC       ability to inhibit serine/threonine-protein phosphatase 2A (PP2A)
CC       activity. Phosphorylation leads to its release from the PP2A complex
CC       and its sequestration by 14-3-3 proteins in the cytoplasm resulting in
CC       its inability to translocate to the nucleus, where it otherwise
CC       inhibits PP2A. {ECO:0000250|UniProtKB:Q96E09}.
CC   -!- SIMILARITY: Belongs to the FAM122 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC078922; AAH78922.1; -; mRNA.
DR   RefSeq; NP_001014051.1; NM_001014029.1.
DR   AlphaFoldDB; Q6AYT4; -.
DR   SMR; Q6AYT4; -.
DR   iPTMnet; Q6AYT4; -.
DR   PhosphoSitePlus; Q6AYT4; -.
DR   PaxDb; 10116-ENSRNOP00000068087; -.
DR   Ensembl; ENSRNOT00000076544.2; ENSRNOP00000068087.1; ENSRNOG00000051051.2.
DR   Ensembl; ENSRNOT00055054780; ENSRNOP00055045274; ENSRNOG00055031640.
DR   Ensembl; ENSRNOT00060039207; ENSRNOP00060032418; ENSRNOG00060022618.
DR   Ensembl; ENSRNOT00065043890; ENSRNOP00065035997; ENSRNOG00065025486.
DR   GeneID; 309420; -.
DR   KEGG; rno:309420; -.
DR   UCSC; RGD:1310316; rat.
DR   AGR; RGD:1310316; -.
DR   CTD; 116224; -.
DR   RGD; 1310316; Pabir1.
DR   eggNOG; ENOG502QTCH; Eukaryota.
DR   GeneTree; ENSGT00390000015476; -.
DR   HOGENOM; CLU_083344_0_0_1; -.
DR   InParanoid; Q6AYT4; -.
DR   OMA; ISHHTDS; -.
DR   OrthoDB; 3028556at2759; -.
DR   PhylomeDB; Q6AYT4; -.
DR   PRO; PR:Q6AYT4; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000051051; Expressed in heart and 19 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0016604; C:nuclear body; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0004865; F:protein serine/threonine phosphatase inhibitor activity; ISS:UniProtKB.
DR   GO; GO:0044818; P:mitotic G2/M transition checkpoint; ISS:UniProtKB.
DR   GO; GO:0030307; P:positive regulation of cell growth; ISS:UniProtKB.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   InterPro; IPR026716; PBIR1/2/3.
DR   PANTHER; PTHR22227:SF3; PPP2R1A-PPP2R2A-INTERACTING PHOSPHATASE REGULATOR 1; 1.
DR   PANTHER; PTHR22227; UNCHARACTERIZED; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Isopeptide bond; Nucleus; Phosphoprotein;
KW   Protein phosphatase inhibitor; Reference proteome; Ubl conjugation.
FT   CHAIN           1..286
FT                   /note="P2R1A-PPP2R2A-interacting phosphatase regulator 1"
FT                   /id="PRO_0000089691"
FT   REGION          1..46
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          166..187
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          238..286
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        238..271
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         34
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96E09"
FT   MOD_RES         36
FT                   /note="Phosphoserine; by CHEK1"
FT                   /evidence="ECO:0000250|UniProtKB:Q96E09"
FT   MOD_RES         44
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96E09"
FT   MOD_RES         47
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96E09"
FT   MOD_RES         61
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         75
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         142
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         146
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         148
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96E09"
FT   MOD_RES         186
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96E09"
FT   MOD_RES         188
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         266
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DB52"
FT   MOD_RES         269
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         275
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96E09"
FT   CROSSLNK        88
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1)"
FT                   /evidence="ECO:0000250|UniProtKB:Q96E09"
SQ   SEQUENCE   286 AA;  30472 MW;  14A2B674623D2688 CRC64;
     MAQEKMELDL ELPAGTGASP AEGGGPGSGG LRRSNSAPLI HGLSDSSPVF QAEAPSARRN
     STTFPSRHGL LLPASPVRMH SSRLHQIKQE EGMDLINRET VHEREVQTAM QISHSWEESF
     SLSDNDVEKS ASPKRIDFIP VSPAPSPTRG IGKQCFSPSL QSFVSSNGLP PSPIPSPTTR
     FTTRRSQSPI NCIRPSVLGP LKRKCEMETD YQPKRFFQGI TNMLSSDVAQ LSEPGVCVSS
     DTLDGNSSSA GSSCNSPAKV STTTDSPVSP AQAASPFIPV DELSSK
//
